ᐯIᑕTOᖇ ᑎIᘔET, ᗰᗪ
banner
nizet.bsky.social
ᐯIᑕTOᖇ ᑎIᘔET, ᗰᗪ
@nizet.bsky.social
Physician-scientist at UC San Diego, Microbiology, Immunology, Novel Drug and Vaccine Discovery, #IDSky, Mentoring and Supporting STEM Career Development.

Enjoy exploring the outdoors, world cultures, sports, comedy, community.

http://nizetlab.ucsd.edu
see this guy regularly here in San Diego
December 1, 2025 at 12:35 AM
November 28, 2025 at 5:02 PM
November 28, 2025 at 2:59 PM
Still frame of the Osprey
November 27, 2025 at 6:37 PM
November 18, 2025 at 12:23 PM
CTI-111 binds multiple sepsis-associated human cytokines in the complex environment of ex vivo septic serum—highlighting its potential as a multifaceted sepsis therapy

Ongoing work is expanding CTI-111's utility to additional severe infectious or inflammatory conditions

🧵/end

Article @ ACS Nano:
Natural Macrophage Membrane-Coated Nanoparticles as a Multifaceted Sepsis Therapeutic to Sequester Inflammatory and Toxic Mediators
Bacterial sepsis is a life-threatening immune dysregulation triggered by bacterial infection and propagated by a dysfunctional host response, culminating in systemic tissue damage and multiorgan failu...
pubs.acs.org
November 11, 2025 at 11:25 PM
Human macrophage membrane-derived drug candidate CTI-111 sequesters soluble microbial toxins, drivers of inflammation, and pro-inflammatory cytokines from multiple sources. Therapeutic administration of CTI-111 reduces inflammation and improves survival in multiple murine sepsis models

🧵 3/4
November 11, 2025 at 11:25 PM
In the United States, sepsis results in the hospitalization of more than one million patients annually and accounts for nearly one in three hospital deaths. Despite decades of efforts to develop immunoregulatory sepsis therapies, no clinically approved treatments exist.

🧵2/4
November 11, 2025 at 11:25 PM